Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$202,004 Mln
Revenue (TTM)
$8,715 Mln
Net Profit (TTM)
$0 Mln
ROE
0.2 %
ROCE
15.6 %
P/E Ratio
82.4
P/B Ratio
11.7
Industry P/E
64.27
EV/EBITDA
66.5
Div. Yield
0 %
Debt to Equity
0
Book Value
$--
EPS
$6.8
Face value
--
Shares outstanding
358,417,984
CFO
$13,270.40 Mln
EBITDA
$13,486.10 Mln
Net Profit
$10,796.20 Mln
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
---|---|---|---|---|---|---|---|
Intuitive Surgical (ISRG)
| 7.6 | 16.3 | -6.5 | 40.8 | 37.6 | 25.6 | 26.0 |
BSE Sensex*
| 4.7 | 4.2 | 7.8 | 10.7 | 15.8 | 22.1 | 11.5 |
S&P 100
| -0.4 | 13.8 | -3.3 | 14.8 | 17.6 | 16.3 | 12.0 |
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
---|---|---|---|---|---|---|---|
Intuitive Surgical (ISRG)
| 54.2 | 27.1 | -26.1 | 31.8 | 38.4 | 23.4 | 31.0 |
S&P 100
| 29.0 | 30.8 | -22.1 | 27.6 | 19.3 | 29.5 | -5.8 |
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
---|---|---|---|---|---|---|---|---|
Intuitive Surgical (ISRG)
|
561.6 | 202,004.4 | 8,714.9 | 2,476.1 | 28.2 | 15 | 82.4 | 11.7 |
135.6 | 234,530.4 | 42,344.0 | 13,502.0 | 19.0 | 30.5 | 17.5 | 4.8 | |
177.1 | 50,273.7 | 20,867.0 | 1,498.0 | 11.0 | 5.9 | 34 | 2.0 | |
106.7 | 156,880.9 | 17,553.0 | 2,032.0 | 16.0 | 9.5 | 77.4 | 7.1 | |
196.4 | 140,350.1 | 23,820.0 | 3,765.0 | 20.4 | 7.4 | 38 | 2.8 | |
78.0 | 45,754.8 | 5,538.8 | 4,180.7 | 22.0 | 42.6 | 32.2 | 4.5 | |
521.7 | 41,666.6 | 3,931.8 | 895.0 | 29.5 | 58.4 | 47.8 | 28.8 | |
253.4 | 36,904.6 | 5,021.5 | 1,313.3 | 31.8 | 24.5 | 28.2 | 6.7 | |
394.7 | 150,653.3 | 23,218.0 | 2,859.0 | 15.9 | 8.6 | 53.2 | 7.2 | |
413.9 | 155,550.2 | 42,898.0 | 6,515.0 | 18.5 | 13.2 | 24.2 | 3.1 |
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da... Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California. Read more
CEO & Director
Dr. Gary S. Guthart Ph.D.
CEO & Director
Dr. Gary S. Guthart Ph.D.
Headquarters
Sunnyvale, CA
Website
The total asset value of Intuitive Surgical Inc (ISRG) stood at $ 20,759 Mln as on 31-Mar-25
The share price of Intuitive Surgical Inc (ISRG) is $561.63 (NASDAQ) as of 19-May-2025 16:23 EDT. Intuitive Surgical Inc (ISRG) has given a return of 37.65% in the last 3 years.
Intuitive Surgical Inc (ISRG) has a market capitalisation of $ 202,004 Mln as on 16-May-2025. As per Value Research classification, it is a Large Cap company.
The P/B ratio of Intuitive Surgical Inc (ISRG) is 11.74 times as on 16-May-2025, a 230% premium to its peers’ median range of 3.56 times.
The P/E ratio of Intuitive Surgical Inc (ISRG) is 82.40 times as on 16-May-2025, a 28% premium to its peers’ median range of 64.27 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Intuitive Surgical Inc (ISRG) and enter the required number of quantities and click on buy to purchase the shares of Intuitive Surgical Inc (ISRG).
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
The CEO & director of Dr. Gary S. Guthart Ph.D.. is Intuitive Surgical Inc (ISRG), and CFO & Sr. VP is Dr. Gary S. Guthart Ph.D..
There is no promoter pledging in Intuitive Surgical Inc (ISRG).
Some of the close peers are:
Company | Market Cap($ Mln) |
---|---|
22,453
|
|
15,328
|
|
15,231
|
|
14,764
|
|
13,442
|
|
4,902
|
|
4,502
|
|
4,098
|
|
3,622
|
Intuitive Surgical Inc. (ISRG) | Ratios |
---|---|
Return on equity(%)
|
15.04
|
Operating margin(%)
|
28.2
|
Net Margin(%)
|
28.41
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Intuitive Surgical Inc (ISRG) was $0 Mln.